Literature DB >> 7125250

Morphine increases myocardial infarction size in rats.

W Markiewicz, J P Finberg, C Lichtig.   

Abstract

Morphine anesthesia is often recommended in patients with reduced cardiac reserve. As the effect of morphine on the balance between myocardial oxygen supply and demand is not well understood, the effect of large doses of morphine (3 mg/kg, subcutaneously) on experimental myocardial infarction size in the rat was evaluated. Morphine was administered 10 minutes before thoracotomy and coronary artery ligation. Myocardial infarction size was assessed by histologic techniques 48 hours later. Rats given morphine developed significantly larger infarctions than did rats receiving an injection of saline (45.8% of left ventricular area versus 35.3%, p less than 0.05). The data indicate that morphine increase the area of myocardial ischemia when administered before coronary artery occlusion in rats.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7125250

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  3 in total

1.  Spinal Neuronal NOS Signaling Contributes to Morphine Cardioprotection in Ischemia Reperfusion Injury in Rats.

Authors:  Lingling Jiang; Jun Hu; Shufang He; Li Zhang; Ye Zhang
Journal:  J Pharmacol Exp Ther       Date:  2016-06-29       Impact factor: 4.030

2.  A study of the clinical profile of right ventricular infarction in context to inferior wall myocardial infarction in a tertiary care centre.

Authors:  Daanish Aijaz Chhapra; Sanket Kaushik Mahajan; Sanjay Tukaram Thorat
Journal:  J Cardiovasc Dis Res       Date:  2013-11-13

Review 3.  Prospects for Creation of Cardioprotective and Antiarrhythmic Drugs Based on Opioid Receptor Agonists.

Authors:  Leonid N Maslov; Igor Khaliulin; Peter R Oeltgen; Natalia V Naryzhnaya; Jian-Ming Pei; Stephen A Brown; Yury B Lishmanov; James M Downey
Journal:  Med Res Rev       Date:  2016-05-16       Impact factor: 12.944

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.